Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
12/08 CHUGAI PHARMACEUTICAL : Findings from Chugai Pharmaceutical Yields New Data on H..
12/08 FOUNDATION MEDICINE : Researchers at Foundation Medicine Inc. Report New Data on..
12/08 ROCHE : University of Southampton - New cancer drug shows promise in helping pat..
12/08 ROCHE : Avastin (bevacizumab) plus chemotherapy receives FDA approval for platin..
12/08 Sanofi mulls counterbid for Actelion amid J&J talks
12/08 ROCHE : announces European approval of Venclyxto for people with hard-to-treat c..
12/08 ROCHE : Morgan Freeman Joins Stand Up to Cancer, Genentech in New PSA
12/07 ROCHE : FDA Approves Genentech's Avastin (Bevacizumab) Plus Chemotherapy for a S..
12/07 ROCHE : New cancer drug shows promise in helping patients with blood cancer
12/07 FOUNDATION MEDICINE INC. : Receives Average Recommendation of Hold from Analysts
12/07 ROCHE : Approval of multi-product funding proposal with Roche
12/07 ROCHE : Ventana Medical lays off 84 workers in Oro Valley
12/06 ROCHE : FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy ..
12/06 ROCHE : Federal Contracts Awarded to Companies in Indiana (Dec. 6)
12/06 ROCHE : MILITARY $5.36 Million Federal Contract Awarded to Roche Diagnostics
12/05 ROCHE : Major PHARMAC funding package agreed with Roche
12/05 ROCHE : Gazyva/Gazyvaro Helped People With Previously Untreated Follicular Lymph..
12/05 ROCHE : New Cancer Drug Shows Promise in Helping Patients with Blood Cancer
12/04 GENENTECH : ’s Gazyva Helped People With Previously Untreated Follicular L..
12/02 SENSEONICSHOLDINGS,INC. (NYSEMKT : SENS) Files An 8-K Entry into a Material Defi..
12/01 CHUGAI PHARMACEUTICAL : Data on Bisphosphonates Reported by Researchers at Chuga..
12/01 ROCHE : Merck Expands Distribution Agreement with Roche - Press Release issued b..
12/01 CHUGAI PHARMACEUTICAL : Filing for Approval of 'Actemra' for Additional Indicati..
12/01 ROCHE : Presolicitation - Notice of Intent to Sole Source-Roche reagents
12/01 ROCHE : Presolicitation Notice - 66-- Notice of Intent to Sole Source-Roche reag..
11/30 ROCHE : The Promise and Challenge of Big Data for Pharma
11/30 ROCHE : Special Notice - 65-- 544-17-1-023-0034-Roche Diag - Hepatitis C-544 EME..
11/29 ROCHE : to sell U.S. plant to Patheon, saving about 200 jobs
11/29 The Bank of New York Mellon Corp Increases Position in Foundation Medicine In..
11/29 PATHEON : ADDING MULTIMEDIA Patheon to Acquire State-of-the-Art Manufacturing Si..
11/28 NANOPHASE TECHNOLOGIES CORPORATION ( : NANX) Files An 8-K Entry into a Material ..
11/28 Global Hepatitis C Drug Market - Merck & Co, Kenilworth, Roche, Basel GlaxoSm..
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/27 ROCHE : Road construction works
11/26 FOUNDATION MEDICINE INC. : (Fmi) Coo Sold $144,341.73 in Stock
11/26 Johnson & Johnson approaches Actelion about takeover deal
11/25DJJ&J Approaches Swiss Firm Actelion About Potential Deal
11/25DJJohnson & Johnson Approaches Swiss Firm Actelion About Potential Deal -- Upda..
11/25 French cancer specialist Innate Pharma can remain independent, for now - CEO
11/25 ROCHE : Diagnostics Operations Assigned Patent
11/23 GLOBAL NON-INVASIVE PRENATAL TESTING : Illumina, Thermo Fisher, Roche, Beckman C..
11/23 ROCHE : Provides Actionable Strategies to Improve Leadership Performance in New ..
11/22 Global Influenza Market - AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline,..
11/22 FOUNDATION MEDICINE : "Don't Guess. Test." Campaign Aims to Increase Awareness o..
11/22 ROCHE : Provides Actionable Strategies to Improve Leadership Performance in New ..
11/18 ROCHE : Sector Two Maines - Construction work for a second tank to tank L Angira..
11/18 ROCHE : Biotech innovator continues on a fast track
11/18 Top British American Tobacco investor Woodford says backs Reynolds deal
11/18 Biotech innovator continues on a fast track
11/17 HALOZYME THERAPEUTICS : Announces Broad Clinical Collaboration Agreement To Eval..
11/17 ROCHE : Sign materials
11/17 ROCHE : Topographical services
11/15 Global Anti Obesity Drugs Market 2016- Pfizer, Merck, Roche, GlaxoSmithKline,..
11/15 ROCHE : Dan Zabrowski Joins Decheng Capital As Venture Partner
11/15 ROCHE : launches imCORE, a global network of cancer immunotherapy centers of exc..
11/14 ROCHE : Phase III GiACTA Study Shows Genentech's Actemra(R) is Superior to Stero..
11/14 ROCHE : Phase III GiACTA study shows Roche's Actemra/RoActemra is superior to st..
11/12 YESTAR INTERNATIONAL COMPNY : to buy stake in diagnostics products firm
11/12 ROCHE : Phase III GiACTA Study Shows Genentech’s Actemra® is Superior to S..
11/11 OPIANT PHARMACEUTICALS : Announces Appointment of Thomas T. Thomas to Board of D..
11/11 ROCHE : Russia's Biocad to continue sales of anti-cancer drugs in Sri Lanka desp..
11/11 ROCHE : Diagnostics Operations Assigned Patent
11/11 BRISTOL MYERS SQUIBB : Samsung Biologics veut devenir leader mondial
11/10 Foundation Medicine and Sarah Cannon Collaborate to Advance Personalized Medi..
11/10 NOVOGEN : Licenses Phase II-Ready Molecule from Genentech for Development in Gli..
11/10 FOUNDATION MEDICINE : Flatiron Health and Foundation Medicine Unveil Powerful On..
11/10 ROCHE : Prothena Reports Results from Phase 1b Study of PRX002 Demonstrating Rob..
11/09 Pharma, biotech shares soar as Trump win calms pricing talk
11/09 Pharma, biotech shares soar as Trump win calms pricing talk
11/09 ROCHE OFFICIAL : the activity of the pharma market in Romania is difficult to pl..
11/08 ROCHE : Federal Contracts Awarded by Federal Agencies in Illinois (Nov. 8)
11/08 FOUNDATION MEDICINE INC. : (FMI) is Trading Higher on Unusual Volume for Novembe..
11/08 ROCHE : $3.85 Billion Federal Contract Awarded to Genentech USA
11/08 5 Biggest Pharmaceutical Companies by Market Cap
11/07 Erythropoietin Market (EPO) with Focus on Asia – Industry Analysis with..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( CHF)
Sales 2016 51 112 M
EBIT 2016 17 690 M
Net income 2016 11 162 M
Debt 2016 11 052 M
Yield 2016 3,88%
P/E ratio 2016 17,04
P/E ratio 2017 15,31
EV / Sales 2016 3,98x
EV / Sales 2017 3,70x
Capitalization 192 358 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 284  CHF
Spread / Average Target 29%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.189 184
JOHNSON & JOHNSON8.05%301 952
ROCHE HOLDING LTD.-19.97%189 184
PFIZER INC.-3.38%187 755
NOVARTIS AG-20.79%178 671
MERCK & CO., INC.13.82%165 759
More Results